ADAPTIMMUNE TRANSFORMING T CELL THERAPY
USPTO Trademark Record · Serial No. 79178123
Trademark details
It was initially claimed by Adaptimmune Limited on 20151014.
That brand applies to the following goods and services:Pharmaceutical preparations; immunotherapy preparations; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors, Medical treatment services; immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the ADAPTIMMUNE TRANSFORMING T CELL THERAPY trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
